Roseola Infantum

Roseola Infantum

National Organization for Rare Disorders, Inc.

Important

It is possible that the main title of the report Roseola Infantum is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.

Synonyms

  • Exanthem Subitum
  • Pseudorubella
  • Sixth Disease

Disorder Subdivisions

  • None

General Discussion

Roseola Infantum is an acute infectious disorder of infants or very young children. Characterized by high fever and the appearance of a red skin rash, this disorder may resemble Rubella after the fever has disappeared. Seizures may also occur.

Symptoms

The incubation period before symptoms of Roseola Infantum appear is approximately 5 to 15 days. A high fever begins abruptly and usually lasts for 3 or 4 days without an obvious identifiable cause. Convulsions are common during this period. Low levels of white blood cells (leukopenia) may occur by the 3rd day. The spleen may be slightly enlarged. The fever usually breaks on the 4th day, and a characteristic rash of red spots or elevated (macular or maculopapular) spots appears. This rash may cover the chest and abdomen, although it often appears in a mild form on the face and extremities. Temperature returns to normal at this stage, and the child usually feels and acts well. In some cases, the rash may be so mild that it goes unnoticed.

Causes

In most affected infants and children, Roseola Infantum is caused by infection with a herpesvirus known as human herpesvirus 6 (HHV-6). Less commonly, the condition is thought to result from infection with human herpesvirus 7 (HHV-7). Although the infection is known to spread from person to person, the specific mode of transmission remains unknown.

Affected Populations

Roseola Infantum most commonly affects infants and children between the ages of six months and two years. The condition typically occurs during the spring and fall months and, in some cases, has been reported in local outbreaks.

Standard Therapies

Roseola Infantum usually spontaneously resolves within a few days. Therefore, treatment of the condition is primarily symptomatic and supportive. Such measures may include providing certain medications to help reduce fever (antipyretics), such as acetaminophen or ibuprofen. However, aspirin must be avoided, since there appears to be an association between the onset of Reye Syndrome and the use of aspirin in children or adolescents with certain viral illnesses. Reye Syndrome, a rare but potentially life-threatening condition, is primarily characterized by distinctive, fatty changes of the liver and sudden inflammation and swelling of the brain (acute encephalopathy). (For more information on this disorder, please choose "Reye" as your search term in the Rare Disease Database.)



According to reports in the medical literature, if infants or children are prone to experiencing convulsions, the administration of certain sedatives when there is a sudden onset of fever may be helpful in preventing convulsive episodes in association with Roseola Infantum.

Investigational Therapies

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.



For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:



Tollfree: (800) 411-1222

TTY: (866) 411-1010

Email: prpl@cc.nih.gov



For information about clinical trials sponsored by private sources, contact:

www.centerwatch.com

References

TEXTBOOKS

Nelson Textbook of Pediatrics, 15th Ed.: Richard E. Behrman, Editor; W.B. Saunders Company, 1996. Pp. 890-92.



JOURNAL ARTICLES

Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.

Br J Dermatol. 2007 Nov;157(5):934-40. Epub 2007 Sep 13.



Caselli E, Di Luca D. Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol. 2007 Jul;30(3):173-87.



Dyer JA. Childhood viral exanthems. Pediatr Ann. 2007 Jan;36(1):21-9.



Millichap JG, Millichap JJ. Role of viral infections in the etiology of febrile seizures.

Pediatr Neurol. 2006 Sep;35(3):165-72.



Identification of Human Herpes Virus-6 as a Causal Agent for Exanthem Subtum. K. Yamanishi et al.; Lancet (May 14 1988; 1(8594)). Pp. 1065-67.



Five Cases of Thrombocytopenia Induced by Primary Human Herpes Virus 6 Infection. T. Yoshikawa et al.; Acta Paediatr Jpn (Jun 1998; 40(3)). Pp. 278-81.



Risk Factors for the Early Acquisition of Human Herpes Virus 6 and Human Virus 7 Infections in Children. B.P. Lanphear et al.; Pediatr Infect Dis J (Sep 1998; 17(9)). Pp. 792-95.



HHV 6,7 AND 8. Recently Discovered Herpes Viruses Explain the Etiology of Well-Known Diseases. T. Bergstrom Lakartidningen (Jun 30 1999; 96(26-27)). Pp. 3161-65.



Human Herpes Virus 6: An Emerging Pathogen. G. Campadelli-Fiume et al.; Emerg Infect Dis (May-Jun 1999; 5(3)). Pp. 353-66.

Resources

Centers for Disease Control and Prevention

1600 Clifton Road NE

Atlanta, GA 30333

Tel: (404)639-3534

Tel: (800)232-4636

TDD: (888)232-6348

Email: cdcinfo@cdc.gov

Internet: http://www.cdc.gov/



NIH/National Institute of Allergy and Infectious Diseases

Office of Communications and Government Relations

6610 Rockledge Drive, MSC 6612

Bethesda, MD 20892-6612

Tel: (301)496-5717

Fax: (301)402-3573

Tel: (866)284-4107

TDD: (800)877-8339

Email: ocpostoffice@niaid.nih.gov

Internet: http://www.niaid.nih.gov/



American Academy of Allergy, Asthma and Immunology

611 East Wells Street

Milwaukee, WI 53202

Tel: (414)272-6071

Fax: (414)276-3349

Tel: (800)822-2762

Email: info@aaaai.org

Internet: http://www.aaaai.org



Genetic and Rare Diseases (GARD) Information Center

PO Box 8126

Gaithersburg, MD 20898-8126

Tel: (301)251-4925

Fax: (301)251-4911

Tel: (888)205-2311

TDD: (888)205-3223

Internet: http://rarediseases.info.nih.gov/GARD/



For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use . How this information was developed to help you make better health decisions.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.